Edition:
United States

Integra LifeSciences Holdings Corp (IART.OQ)

IART.OQ on NASDAQ Stock Exchange Global Select Market

42.49USD
13 Jan 2017
Change (% chg)

-- (--)
Prev Close
$42.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
322,948
52-wk High
$45.49
52-wk Low
$27.41

IART.OQ

Chart for IART.OQ

About

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical... (more)

Overall

Beta: 0.80
Market Cap(Mil.): $3,177.06
Shares Outstanding(Mil.): 74.77
Dividend: --
Yield (%): --

Financials

  IART.OQ Industry Sector
P/E (TTM): 54.66 34.34 30.92
EPS (TTM): 0.78 -- --
ROI: 3.66 13.22 14.82
ROE: 7.89 16.81 16.24

BRIEF-Integra lifesciences sees FY 2017 adj shr $1.91 to $1.97

* Integra Lifesciences Holdings - expects Q4 2016 gaap and adjusted diluted EPS to be at or above mid-point of prior guidance range of $0.32 to $0.35 and $0.50 to $0.53 respectively

Jan 10 2017

BRIEF-Integra Lifesciences to buy Derma Sciences

* Derma Sciences to be acquired by Integra Lifesciences for $7.00 per share of common stock in cash

Jan 10 2017

BRIEF-Integra Lifesciences Holdings files for potential mixed shelf offering - SEC filing

* Files for potential mixed shelf offering; size not disclosed - SEC filing Source text : http://bit.ly/2e8kDd6 Further company coverage:

Nov 04 2016

BRIEF-Integra Lifesciences announces plans for a two-for-one stock split and increase in authorized shares

* Integra Lifesciences announces plans for a two-for-one stock split and increase in authorized shares

Oct 27 2016

BRIEF-Integra LifeSciences Q3 GAAP earnings per share $0.50

* Integra lifesciences reports third quarter 2016 financial results

Oct 27 2016

Earnings vs. Estimates